Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: Successes and barriers

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 4, 2010, Pages 983-991

  Vissink, Arjan ^a   Mitchell, James B ^b   Baum, Bruce J ^c   Limesand, Kirsten H ^d   Jensen, Siri Beier ^e   Fox, Philip C ^f   Elting, Linda S ^g   Langendijk, Johannes A ^a   Coppes, Robert P ^a   Reyland, Mary E ^h  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f PC Fox Consulting   (Italy)

^g UNIVERSITY OF TEXAS   (United States)

^h UNIVERSITY OF COLORADO   (United States)

Author keywords

Gene transfer; Hyposalivation; Palliative care; Prevention; Radiotherapy; Stem cell therapy; Xerostomia

Indexed keywords

GENE THERAPY; GENE TRANSFER; STEM CELLS; TISSUE;

HYPOSALIVATION; PALLIATIVE CARE; PREVENTION; STEM CELL THERAPY; XEROSTOMIA;

RADIOTHERAPY;

AMIFOSTINE; KERATINOCYTE GROWTH FACTOR; SOMATOMEDIN; TEMPOL; RADIOPROTECTIVE AGENT; SALIVA SUBSTITUTE;

ACUPUNCTURE; APOPTOSIS; CANCER GENE THERAPY; DNA DAMAGE; DRUG EFFICACY; DRUG TOLERABILITY; HEAD AND NECK CANCER; HUMAN; IRRADIATION; PATHOPHYSIOLOGY; PH; PRIORITY JOURNAL; PROTON THERAPY; RADIATION INJURY; REVIEW; SALIVARY GLAND; SALIVARY GLAND DISEASE; STEM CELL TRANSPLANTATION; XEROSTOMIA; GENE THERAPY; HEAD AND NECK NEOPLASMS; PROCEDURES; RADIATION INJURIES; RADIATION RESPONSE; TRENDS;

GENETIC THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY; SALIVA, ARTIFICIAL; SALIVARY GLANDS; STEM CELL TRANSPLANTATION; XEROSTOMIA;

EID: 77958494456     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.06.052     Document Type: Review

References (73)

1. F.R. Burlage, R.P. Coppes, and H. Meertens Parotid and submandibular/sublingual flow during high dose radiotherapy Radiother Oncol 61 2001 271 274
2. A. Vissink, J. Jansma, and F.K.L. Spijkervet Oral sequelae of head and neck radiotherapy Crit Rev Oral Biol Med 14 2003 199 212
3. A.P. Jellema, B.J. Slotman, and P. Doornaert Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer Int J Radiat Oncol Biol Phys 69 2007 751 760
4. J.A. Langendijk, P. Doornaert, and I.M. Verdonck-de Leeuw Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy J Clin Oncol 26 2008 3770 3776
5. S.B. Jensen, A.M. Pedersen, and J. Reibel Xerostomia and hypofunction of the salivary glands in cancer therapy Support Care Cancer 11 2003 207 225
6. S.B. Jensen, A.M.L. Pedersen, and A. Vissink A systematic review of salivary gland hypofunction and xerostomia induced bycancer therapies: Management strategies and economic impact Support Care Cancer 18 2010 1061 1079
7. A. Eisbruch, H.M. Kim, and J.E. Terrell Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer Int J Radiat Oncol Biol Phys 50 2001 695 704
8. C. Dawes Salivary flow patterns and the health of hard and soft oral tissues J Am Dent Assoc 139 Suppl. 2008 18S 24S
9. R. Sas, and C. Dawes The intra-oral distribution of unstimulated and chewing-gum-stimulated parotid saliva Arch Oral Biol 42 1997 469 474
10. Osailan S, Pramanik R, Shirodaria S, et al. Investigating the relationship between hyposalivation and mucosal wetness. Oral Dis. In press.
11. F.A. Stewart, and A.J. Van der Kogel Volume effects in normal tissues G.G. Steel, Basic clinical radiobiology 3rd ed 2002 Arnold London 42 51
12. R.P. Coppes, A. Vissink, and A.W.T. Konings Comparison of radiosensitivity of rat parotid and submandibular glands after different radiation schedules Radiother Oncol 63 2002 321 328
13. A.W.T. Konings, R.P. Coppes, and A. Vissink On the mechanism of salivary gland radiosensitivity Int J Radiat Oncol Biol Phys 62 2005 1187 1194
14. J.O. Dreyer, Y. Sakuma, and G. Seifert Die Strahlen-Sialadenitis. Stadieneinteilung und Immunhistologie Pathologe 10 1989 165 170
15. G.M.R.M. Paardenkooper, L.J.W. Zeilstra, and R.P. Coppes Radiation induced apoptosis is not the cause of acute impairement of rat salivary gland function Int J Radiat Biol 73 1998 641 648
16. J.L. Avila, O. Grundmann, and R. Burd Radiation-induced salivary gland dysfunction results from p53-dependent apoptosis Int J Radiat Oncol Biol Phys 73 2009 523 529
17. K. Abok, U. Brunk, and B. Jung Morphologic and histochemical studies of the deferring radiosensitivity of the ductular and acinar cell of the rat submandibular gland Virchows Arch Cell Pathol 45 1984 443 460
18. R.M. Nagler, Y. Marmary, and P.C. Fox Irradiation-induced damage to the salivary glands: The role of redox-active iron and copper Radiat Res 147 1997 468 475
19. A. Vissink, E.J. 's-Gravenmade, and E.E. Ligeon A functional and chemical study of radiation effects on rat parotid and submandibular/sublingual glands Radiat Res 124 1990 259 265
20. A. Vissink, D. Kalicharan, and E.J. 's-Gravenmade Acute irradiation effects on morphology and function of rat submandibular glands J Oral Pathol Med 20 1991 449 456
21. R.P. Coppes, L.J.W. Zeilstra, and H.H. Kampinga Early to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists Br J Cancer 85 2001 1055 1063
22. L.J. Zeilstra, A. Vissink, and A.W.T. Konings Radiation induced cell loss in rat submandibular gland and its relation to gland function Int J Radiat Biol 76 2000 419 429
23. R.P. Liu, T.J. Fleming, and B.B. Toth Salivary flow rates in patients with head and neck cancer 0.5 to 25 years after radiotherapy Oral Surg Oral Med Oral Pathol 70 1990 724 729
24. J.H. Valdez, J.C. Atkinson, and J.A. Ship Major salivary gland function in patients with radiation-induced xerostomia: Flow rates and sialochemistry Int J Radiat Oncol Biol Phys 25 1993 41 47
25. A. Eisbruch, R.K. Ten Haken, and M.K. Hyungjin Dose, volume and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer Int J Radiat Oncol Biol Phys 45 1999 577 587
26. C.A. Murdoch-Kinch, H.M. Kim, and K.A. Vineberg Dose-effect relationship for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy Int J Radiat Oncol Biol Phys 72 2008 373 382
27. J.M. Roesink, M.A. Moerland, and J.J. Battermann Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region Int J Radiat Oncol Biol Phys 51 2001 938 946
28. C. Ortholan, E. Chamorey, and K. Benezery Modeling of salivary production recovery after radiotherapy using mixed models: Determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function Int J Radiat Oncol Biol Phys 73 2009 178 186
29. Dijkema T, Raaijmakers CPJ, Ten Haken RK, et al. Parotid gland function after radiotherapy: The combined Michigan and Utrecht experience. Int J Radiother Oncol Biol Phys. In press.
30. M.R. Vergeer, P.A. Doornaert, and D.H. Rietveld Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: Results of a nonrandomized prospective study using a standardized follow-up program Int J Radiat Oncol Biol Phys 74 2009 1 8
31. M. Steneker, A. Lomax, and U. Schneider Intensity modulated photon and proton therapy for the treatment of head and neck tumors Radiother Oncol 80 2006 263 267
32. L. Widesott, A. Pierelli, and C. Fiorino Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: Planning comparison and NTCP evaluation Int J Radiat Oncol Biol Phys 72 2008 589 596
33. L. Cozzi, A. Fogliata, and A. Lomax A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours Radiother Oncol 61 2001 287 297
34. A.J. Lomax, M. Goitein, and J. Adams Intensity modulation in radiotherapy: Photons versus protons in the paranasal sinus Radiother Oncol 66 2003 11 18
35. T. van de Water, T. Lomax, and H.P. Bijl Comparative treatment planning study between scanned intensity modulated proton therapy and photon therapy in complex oropharyngeal carcinoma Radiother Oncol 88 Suppl.2 2008 S77 S78
36. T.H. Wasserman, D.M. Brizel, and M. Henk Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and-neck cancer: 2 year follow-up of a prospective, randomized, phase III trial Int J Radiat Oncol Biol Phys 63 2005 985 990
37. M.L. Hensley, K.L. Hagerty, and T. Kewalramani American Society of Clinical Oncology 2008 clinical practice guideline update: Use of chemotherapy and radiation therapy protectants J Clin Oncol 27 2009 127 145
38. F.R. Burlage, J.M. Roesink, and H.H. Kampinga Protection of salivary function by concomitant pilocarpine during radiotherapy: A double-blind, randomized, placebo-controlled study Int J Radiat Oncol Biol Phys 70 2008 14 22
39. M.T. Brennan, L.S. Elting, and F.K.L. Spijkervet Systematic reviews of oral complications from cancer therapies, Oral Care Study Group, MASCC/ISOO: Methodology and quality of theliterature Support Care Cancer 18 2010 979 984
40. A.P. Jellema, B.J. Slotman, and M.J. Muller Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer Cancer 107 2006 544 553
41. P.R. Anné, M. Machtay, and D.I. Rosenthal A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer Int J Radiat Oncol Biol Phys 67 2007 445 452
42. D.M. Brizel, T.H. Wasserman, and M. Henke Phase III randomized trial of amifostine as a radioprotector in head and neck cancer J Clin Oncol 18 2000 3339 3345
43. J.M. Vitolo, A.P. Cotrim, and A.L. Sowers The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model Clin Cancer Res 10 2004 1807 1812
44. A.P. Cotrim, A.L. Sowers, and B.M. Lodde Kinetics of tempol for prevention of xerostomia following head and neck irradiation in a mouse model Clin Cancer Res 11 2005 7564 7568
45. A.P. Cotrim, F. Hyodo, and K. Matsumoto Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging Clin Cancer Res 13 2007 4928 4933
46. K.H. Limesand, S. Said, and S.M. Anderson Suppression of radiation-induced salivary gland dysfunction by IGF-1 PLoS ONE 4 3 2009 e4663
47. I.M. Lombaert, J.F. Brunsting, and P.K. Wierenga Keratinocyte growth factor prevents radiation damage to salivary glands by expansion of the stem/progenitor pool Stem Cells 26 2008 2595 2601
48. A. Teymoortash, F. Müller, and J. Juricko Botulinum toxin prevents radiotherapy-induced salivary gland damage Oral Oncol 45 2009 737 739
49. J.T. Johnson, G.A. Ferretti, and W.J. Nethery Oral pilocarpine for postirradiation xerostomia in patients with head and neck cancer N Engl J Med 329 1993 390 395
50. F.G. LeVeque, F. Montgomery, and D. Potter A multi-centre randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients J Clin Oncol 11 1993 1124 1131
51. F.R. Burlage, J.M. Roesink, and H. Faber Optimum dose range for the amelioration of long term radiation-induced hyposalivation using prophylactic pilocarpine treatment Radiother Oncol 86 2008 347 353
52. F.R. Burlage, H. Faber, and H.H. Kampinga Enhanced proliferation of acinar and progenitor cells by prophylactic pilocarpine treatment underlies the observed amelioration of radiation injury to parotid glands Radiother Oncol 90 2009 253 256
53. C. Scarantino, F. LeVeque, and R.S. Swann Effect of pilocarpine during radiation therapy: Results of RTOG 97-09, a phase III randomised study in head and neck cancer patients J Support Oncol 4 2006 252 258
54. W. Niedermeier, C. Matthaeus, and C. Meyer Radiation-induced hyposalivation and its treatment with oral pilocarpine Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86 1998 541 549
55. J.B. Epstein, and M.M. Schubert Synergistic effect of sialogogues in management of xerostomia after radiation therapy Oral Surg Oral Med Oral Pathol 64 1987 179 182
56. D. Petrone, J.J. Condemi, and R. Fife A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca Arthritis Rheum 46 2002 748 754
57. M. Blom, and T. Lundeberg Long-term follow-up of patients treated with acupuncture for xerostomia and the influence of additional treatment Oral Dis 6 2000 15 24
58. P.A. Johnstone, Y.P. Peng, and B.C. May Acupuncture for pilocarpine-resistant xerostomia following radiotherapy for head and neck malignancies Int J Radiat Oncol Biol Phys 50 2001 353 357
59. R.K.W. Wong, G.W. Jones, and S.M. Sagar A phase I-IIstudy in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy Int J Radiat Oncol Biol Phys 57 2003 472 480
60. F.P. Braga, N.N. Sugaya, and S.K. Hirota The effect of acupuncture on salivary flow rates in patients with radiation-induced xerostomia Minerva Stomatol 57 2008 343 348
61. G. Deng, B.L. Hou, and A.I. Holodny Functional magnetic resonance imaging (fMRI) changes and saliva production associated with acupuncture at L1-2 acupuncture point: A randomized controlled study BMC Complement Altern Med 8 2008 37
62. J. Matzker, and J. Schreiber Synthetischer Speichel zur Therapie der Hyposalien insbesondere bei der radiogenen Sialadenitis Z Laryngol Rinol Otol 51 1972 422 428
63. E.J. 's-Gravenmade, D.A. Roukema, and A.K. Panders The effects of mucin-containing artificial saliva on severe xerostomia Int J Oral Surg 3 1974 435 439
64. W.A. Van der Reijden, H. Van der Kwaak, and A. Vissink Treatment of xerostomia with polymer-based saliva substitutes in patients with Sjögren's syndrome Arthritis Rheum 39 1996 57 69
65. A. Vissink, E.J. 's-Gravenmade, and A.K. Panders A clinical comparison between commercially available mucin- and CMC-containing saliva substitutes Int J Oral Surg 12 1983 232 238
66. G. Regelink, A. Vissink, and H. Reintsema Efficacy of a synthetic polymer based saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia Quintessence Int 29 1998 383 388
67. F. Momm, N.J. Volegova-Neher, and J. Schulte-Mönting Different saliva substitutes for treatment of xerostomia following radiotherapy. A prospective crossover study Strahlenther Onkol 181 2005 231 236
68. B.J. Baum, C. Zheng, and A.P. Cotrim Aquaporin-1 gene transfer to correct radiation-induced salivary hypofunction E. Beitz, Aquaporins. Handbook of experimental pharmacology 2009 Springer-Verlag Heidelberg 403 418
69. C. Delporte, B.C. O'Connell, and X. He Increased fluid secretion after adenovira-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands Proc Natl Acad Sci U S A 94 1997 3268 3273
70. G.M. Preston, and P. Agre Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: Member of an ancient channel family Proc Natl Acad Sci U S A 88 1991 11110 11114
71. X. He, G.A. Kuijpers, and G. Goping A polarized salivary cell monolayer useful for studying transepithelial fluid movement in vitro Pflugers Arch 435 1998 375 381
72. Z. Shan, J. Li, and C. Zheng Increased fluid secretion after adenoviral-mediated transfer of the human aquaporin-1 cDNA to irradiated miniature pig parotid glands Mol Ther 11 2005 444 451
73. I.M. Lombaert, J.F. Brunsting, and P.K. Wierenga Rescue of salivary gland function after stem cell transplantation in irradiated glands PLoS ONE 3 2008 e2063